Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Rebamipide for the Treatment of Xerostomia in Sjögren Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01759108
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:45.919811+00:00
Published At
2020-03-31T00:00:00+00:00
Record Updated At
2020-03-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Improving Symptoms of Dry Mouth in Sj\u0151gren\u0027s Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-03-31"
protocolSection.identificationModule.nctId
"NCT01759108"
protocolSection.identificationModule.officialTitle
"Rebamipide for the Treatment of Xerostomia in Sj\u00f6gren Syndrome"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Improving Symptoms of Dry Mouth in Sjőgren's Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.